European Journal of Haematology
Fecha de publicación: 12 July 2018
Autores: Hanne E. H. Møller, Birgitte S. Preiss, Per Pedersen, Brian Østergaard, Mikael Frederiksen, Niels Abildgaard, Michael B. Møller
Background: Prognostic and predictive markers in multiple myeloma are continuously explored because of the heterogeneity of the tumor biology. Myc protein is the final product from activating MYC oncogene, but the prognostic impact in multiple myeloma is not well described.